Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...
Ascendis Pharma (ASND) has quietly outperformed much of the biotech space this year, with the stock up roughly 60% year to date and about 70% over the past year. This has drawn fresh attention from ...
A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s baby powder was to blame for their ...
Tribune Online on MSN
Police arrest soldiers, two others over fake pharmaceutical products in Lagos
The police in Lagos State have arrested two soldiers and two other persons in connection with a busted fake pharmaceutical drugs company in the Alaba International Market area of the state.It was also ...
Where plaintiffs showed that their federal and state antitrust claims against Johnson & Johnson satisfied all of the ...
BATON ROUGE, La. (WAFB) - Louisiana has settled two federal lawsuits against CVS Health Corporation and its pharmacy benefit ...
The Jefferson County Restricted Opioid Settlement Funds Task Force met for the first time Dec. 5. The task force will solicit, accept and recommend proposals for projects designed to counter opioid ...
Get the latest Takeda (TAK) stock analysis. Read about risks, future prospects, and why peers may offer better value for ...
The program that pays people injured by vaccines irks advocates in the Make America Healthy Again movement. RFK says he'll ...
Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
More recently, the FDA posted two two letters: one backdated for September 9, regarding GSK’s HIV medication Apretude and one backdated for November 24 for Daiichi Sankyo’s tenosynovial giant cell ...
After pressure from the FTC, Teva has asked the FDA to delist hundreds of patents on products for asthma, diabetes, chronic obstructive pulmonary disease and for epinephrine autoinjectors, the agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results